T86.33 Heart-lung transplant infection

Name of the Condition

• Heart-lung transplant infection

Summary

Heart-lung transplant infection refers to infections that occur after a combined heart and lung transplant, affecting the transplanted organs or surrounding tissues. These infections can compromise graft function and patient health, requiring prompt identification and management to prevent severe complications.

Causes

Infections may result from bacterial, viral, or fungal pathogens, often due to immunosuppressive therapy that reduces the body’s ability to fight infections. Surgical site contamination, donor-derived infections, or reactivation of latent pathogens can also contribute to infection development.

Risk Factors

• Immunosuppressive therapy (e.g., corticosteroids, calcineurin inhibitors)
• Prolonged hospitalization or intensive care unit stay
• Pre-existing infections or colonization with resistant organisms
• Donor organ quality or mismatched compatibility
• Surgical complications (e.g., anastomotic leaks, poor wound healing)

Symptoms

• Fever or chills
• Cough, shortness of breath, or chest pain
• Fatigue or malaise
• Purulent drainage or redness at the surgical site
• Decreased organ function (e.g., reduced exercise tolerance, hypoxia)
• Unexplained weight loss or night sweats

Diagnosis

Diagnosis involves clinical evaluation, imaging (e.g., chest X-ray, CT), and laboratory tests (e.g., blood cultures, sputum analysis) to identify the pathogen and assess organ involvement. Biopsies may be performed to confirm infection in transplanted tissues.

Treatment Options

Treatment typically includes targeted antimicrobial therapy (antibiotics, antivirals, or antifungals) based on culture results. Supportive care, such as oxygen therapy or mechanical ventilation, may be needed. Adjustments to immunosuppressive regimens may be necessary to balance infection control and rejection prevention.

Prognosis and Follow-Up

Prognosis depends on the type of infection, timeliness of treatment, and overall patient health. Early intervention improves outcomes, but severe infections can lead to graft dysfunction or failure. Regular monitoring for recurrence or new infections is essential during follow-up visits.

Complications

• Graft rejection or failure
• Sepsis or septic shock
• Respiratory failure requiring mechanical ventilation
• Multi-organ dysfunction
• Chronic lung disease or bronchiolitis obliterans

Lifestyle & Prevention

• Strict adherence to antimicrobial prophylaxis and immunosuppressive regimens
• Avoidance of exposure to sick individuals or crowded places
• Hand hygiene and infection control practices
• Prompt reporting of symptoms to the transplant team
• Vaccinations (e.g., influenza, pneumococcal) as recommended

When to Seek Professional Help

Seek immediate medical attention for fever, worsening respiratory symptoms, or signs of infection (e.g., redness, drainage) at the transplant site. Contact the transplant team for any concerning changes in health status.

Tips for Medical Coders

Code T86.33 is specific to infections following heart-lung transplant. Document the type of infection (e.g., bacterial, viral) and any associated complications (e.g., sepsis, graft dysfunction) to support accurate coding. Ensure clinical correlation with transplant history and treatment details.